Damora Therapeutics, Inc. Common Stock (NASDAQ: DMRA) last traded at $30.82, up 1.68% on the session. The quote above updates while this page is open; the figures below are drawn from Damora Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Damora Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker DMRA. Its market capitalisation is $1.90 billion.
Valuation measures for Damora Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.90B |
|---|---|
| Enterprise value | $1.39B |
| Price / book | 3.69 |
| Beta | 2.04 |
Trailing-twelve-month figures tagged in Damora Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$262.83M |
|---|---|
| Return on equity | -50.93% |
| Cash | $540.51M |
Range and volume for DMRA over the past 52 weeks.
| 52-week high | $38.33 |
|---|---|
| 52-week low | $2.45 |
| Volume | 157.1K |
| Average volume | 576.0K |
| Previous close | $30.31 |
Dividend history for Damora Therapeutics, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.